产品特点
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
DOLAGIS 120 mg chewable tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
One tablet contains:
Carprofen ..................................................................... 120 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet.
Clover-shaped scored beige tablet
The tablet can be divided into four equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In the dog:
Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint
disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
4.3
CONTRAINDICATIONS
Do not use in pregnant and lactating bitches.
Do not use in dogs aged less than 4 months in the absence of specific data.
Do not use in cats.
Do not use in dogs, suffering from cardiac, hepatic or renal disease, when there is a possibility of
gastrointestinal ulceration or bleeding or where there is evidence of blood dyscrasia.
Do not use in case of hypersensitivity to the active substance, to other NSAID and to any of the excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
See sections 4.3 and 4.5.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require a reduced
dosage and careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased ren al
阅读完整的文件